Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,287,185 papers from all fields of science
Search
Sign In
Create Free Account
Bamet-UD2
Known as:
cisdiammine-bis-ursodeoxycholic platinum (II)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Organoplatinum Compounds
Ursodiol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Usefulness of the MRP 2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP 1 B 1
E. Herráez
,
L. Sanchez-Vicente
,
R. Macías
,
O. Briz
,
J. Marin
2017
Corpus ID: 31111422
Tumor response to chemotherapy is often limited by drug export through ABC proteins. To overcome this problem, here we have…
Expand
2015
2015
Tumor-Speci�c Expression of �rganic Anion-Transporting Polypeptides : Transporters as Novel Targets for Cancer Therapy
V. Buxhofer-Ausch
,
Lena Secky
,
+6 authors
T. Thalhammer
2015
Corpus ID: 53993658
1 Department of Medicine, Donauspital, Ludwig Boltzmann, Cluster for Translational Oncology, Vienna, Austria 2 Institute of…
Expand
2010
2010
QM/MM Study of Piano-Stool Ru(II) Complexes Interacting with DNA
Futera Zdenek
,
Tateyama Yoshitaka
,
V. Jaroslav
2010
Corpus ID: 53405108
Piano-stool Ru(II) complexes are interesting for their promising anti-cancer activity against some type of tumours. In medical…
Expand
1998
1998
Comparison of the effects of bischolylglycinatechloro-platinum(II) versus cisplatin on liver regeneration after partial hepatectomy.
M. Herrera
,
M. F. Palomero
,
R. Macías
,
Maria A. Serrano
,
Jose J.G. Marin
Anticancer Research
1998
Corpus ID: 24181707
BACKGROUND Regional chemotherapy by intraportal administration has been envisaged as a useful strategy to prevent the high rate…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required